Learn More
INTRODUCTION This study was undertaken to evaluate the efficacy, safety, and tolerability of policosanol, a new cholesterol-lowering drug, in patients with type II hypercholesterolemia and additional coronary risk factors. PATIENTS AND METHODS After 5 weeks of a standard step-1 lipid-lowering diet, 437 patients were randomized to receive, under(More)
  • 1